Abstract

PurposeTransplantation of pancreatic islets to Type 1 diabetes patients is hampered by inflammatory reactions at the transplantation site leading to dysfunction and death of insulin producing beta-cells. Recently we have shown that co-transplantation of neural crest stem cells (NCSCs) together with the islet cells improves transplantation outcome. The aim of the present investigation was to describe in vitro interactions between NCSCs and insulin producing beta-TC6 cells that may mediate protection against cytokine-induced beta-cell death.ProceduresBeta-TC6 and NCSC cells were cultured either alone or together, and either with or without cell culture inserts. The cultures were then exposed to the pro-inflammatory cytokines IL-1β and IFN-γ for 48 hours followed by analysis of cell death rates (flow cytometry), nitrite production (Griess reagent), protein localization (immunofluorescence) and protein phosphorylation (flow cytometry).ResultsWe observed that beta-TC6 cells co-cultured with NCSCs were protected against cytokine-induced cell death, but not when separated by cell culture inserts. This occurred in parallel with (i) augmented production of nitrite from beta-TC6 cells, indicating that increased cell survival allows a sustained production of nitric oxide; (ii) NCSC-derived laminin production; (iii) decreased phospho-FAK staining in beta-TC6 cell focal adhesions, and (iv) decreased beta-TC6 cell phosphorylation of ERK(T202/Y204), FAK(Y397) and FAK(Y576). Furthermore, co-culture also resulted in cadherin and beta-catenin accumulations at the NCSC/beta-TC6 cell junctions. Finally, the gap junction inhibitor carbenoxolone did not affect cytokine-induced beta-cell death during co-culture with NCSCs.ConclusionIn summary, direct contacts, but not soluble factors, promote improved beta-TC6 viability when co-cultured with NCSCs. We hypothesize that cadherin junctions between NCSC and beta-TC6 cells promote powerful signals that maintain beta-cell survival even though ERK and FAK signaling are suppressed. It may be that future strategies to improve islet transplantation outcome may benefit from attempts to increase beta-cell cadherin junctions to neighboring cells.

Highlights

  • Type 1 diabetes is an autoimmune disease that results in destruction of the insulin-producing beta-cells

  • We observed that beta-TC6 cells co-cultured with neural crest stem cells (NCSCs) were protected against cytokine-induced cell death, but not when separated by cell culture inserts

  • This occurred in parallel with (i) augmented production of nitrite from beta-TC6 cells, indicating that increased cell survival allows a sustained production of nitric oxide; (ii) NCSC-derived laminin production; (iii) decreased phospho-focal adhesion kinase (FAK) staining in beta-TC6 cell focal adhesions, and (iv) decreased beta-TC6 cell phosphorylation of extracellular signalregulated kinase (ERK)(T202/Y204), FAK(Y397) and FAK(Y576)

Read more

Summary

Introduction

Type 1 diabetes is an autoimmune disease that results in destruction of the insulin-producing beta-cells. Cytokines, such as IL-1b, TNF-a and IFN-c, induce beta-cell death in vitro; and the local release of the same cytokines has been proposed to participate in pancreatic beta-cell destruction in vivo [1]. Cytokine-induced signaling involves the activation of mitogen-activated protein kinases (MAPK), c-Jun NH2-terminal kinase (JNK), extracellular signalregulated kinase (ERK), and p38 MAPK [4,5]. In addition to the mitogen-activated protein kinases, IL-1b and TNF-a–induced signaling results in activation of the pro-inflammatory transcription factor NF-kB [6]. It has been suggested that in rodent islets, cytokine-induced cell death is caused by increased nitric oxide production, which results from activation of NF-kB–mediated inducible nitric oxide synthase gene transcription [6,7]

Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.